123 related articles for article (PubMed ID: 19620326)
1. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Miró JM; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres CA; Gatell JM; Jiménez de Anta MT; Marco F;
Antimicrob Agents Chemother; 2009 Oct; 53(10):4172-7. PubMed ID: 19620326
[TBL] [Abstract][Full Text] [Related]
2. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Castañeda X; García-De-la-Mària C; Gasch O; Pericàs JM; Soy D; Cañas-Pacheco MA; Falces C; García-González J; Hernández-Meneses M; Vidal B; Almela M; Quintana E; Tolosana JM; Fuster D; Llopis J; Dahl A; Moreno A; Marco F; Miró JM;
J Antimicrob Chemother; 2021 May; 76(6):1539-1546. PubMed ID: 33837406
[TBL] [Abstract][Full Text] [Related]
4. Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
García-de-la-Mària C; Gasch O; Castañeda X; García-González J; Soy D; Cañas MA; Ambrosioni J; Almela M; Pericàs JM; Téllez A; Falces C; Hernández-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Moreno A; Marco F; Miró JM;
J Antimicrob Chemother; 2020 Dec; 75(12):3586-3592. PubMed ID: 32853336
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
Yang SJ; Xiong YQ; Boyle-Vavra S; Daum R; Jones T; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3161-9. PubMed ID: 20547804
[TBL] [Abstract][Full Text] [Related]
6. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus.
Huang DB; Gaukel E; Kerzee N; Borroto-Esoda K; Lowry S; Xiong YQ; Abdelhady W; Bayer AS
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0050821. PubMed ID: 34097491
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography.
Shah SU; Xiong YQ; Abdelhady W; Iwaz J; Pak Y; Schuch R; Cassino C; Lehoux D; Bayer AS
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340988
[TBL] [Abstract][Full Text] [Related]
9. Emerging issues on
García de la Mària C; Cañas MA; Fernández-Pittol M; Dahl A; García-González J; Hernández-Meneses M; Cuervo G; Moreno A; Miró JM; Marco F
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):281-293. PubMed ID: 36744387
[TBL] [Abstract][Full Text] [Related]
10. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
Lee YC; Chen PY; Wang JT; Chang SC
BMC Pharmacol Toxicol; 2019 May; 20(1):25. PubMed ID: 31060599
[TBL] [Abstract][Full Text] [Related]
11. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
Garcia-de-la-Maria C; Xiong YQ; Pericas JM; Armero Y; Moreno A; Mishra NN; Rybak MJ; Tran TT; Arias CA; Sullam PM; Bayer AS; Miro JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264848
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F; Manuel O; Miró JM
J Antimicrob Chemother; 2019 Sep; 74(9):2626-2630. PubMed ID: 31298264
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
Galanter KM; Ho J
Am J Health Syst Pharm; 2019 Jul; 76(14):1033-1036. PubMed ID: 31201773
[TBL] [Abstract][Full Text] [Related]
14. AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.
Castañeda X; García-de-la-Mària C; Gasch O; Pericas JM; Armero Y; Soy D; García-González J; Falces C; Ninot S; Almela M; Ambrosioni J; Quintana E; Vidal B; Fuster D; Llopis J; Soto S; Moreno A; Marco F; Miró JM;
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373187
[TBL] [Abstract][Full Text] [Related]
15. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
[TBL] [Abstract][Full Text] [Related]
16. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
[TBL] [Abstract][Full Text] [Related]
17. Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
Kato H; Hagihara M; Murakami E; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Uno B; Mikamo H
Chemotherapy; 2018; 63(1):13-19. PubMed ID: 29130946
[TBL] [Abstract][Full Text] [Related]
18. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
Reissier S; Saleh-Mghir A; Guerin F; Massias L; Ghout I; Sinel C; Cattoir V; Cremieux AC
J Antimicrob Chemother; 2018 Apr; 73(4):981-986. PubMed ID: 29329389
[TBL] [Abstract][Full Text] [Related]
19. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593
[TBL] [Abstract][Full Text] [Related]
20. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
